In patients with type 2 diabetes mellitus (T2DM), the maximum renal glucose reabsorptive capacity is increased, probably through upregulation of SGLT2, although conflicting data exist in the literature [3,4]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.